Literature DB >> 22657349

Mitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stress.

Eberhard Schulz1, Philip Wenzel, Thomas Münzel, Andreas Daiber.   

Abstract

SIGNIFICANCE: Oxidative stress is a well established hallmark of cardiovascular disease and there is strong evidence for a causal role of reactive oxygen and nitrogen species (RONS) therein. RECENT ADVANCES: Improvement of cardiovascular complications by genetic deletion of RONS producing enzymes and overexpression of RONS degrading enzymes proved the involvement of these species in cardiovascular disease at a molecular level. Vice versa, overexpression of RONS producing enzymes as well as deletion of antioxidant enzymes was demonstrated to aggravate cardiovascular complications. CRITICAL ISSUES: With the present overview we present and discuss different pathways how mitochondrial RONS interact (crosstalk) with other sources of oxidative stress, namely NADPH oxidases, xanthine oxidase and an uncoupled nitric oxide synthase. The potential mechanisms of how this crosstalk proceeds are discussed in detail. Several examples from the literature are summarized (including hypoxia, angiotensin II mediated vascular dysfunction, cellular starvation, nitrate tolerance, aging, hyperglycemia, β-amyloid stress and others) and the underlying mechanisms are put together to a more general concept of redox-based activation of different sources of RONS via enzyme-specific "redox switches". Mitochondria play a key role in this concept providing redox triggers for oxidative damage in the cardiovascular system but also act as amplifiers to increase the burden of oxidative stress. FUTURE DIRECTIONS: Based on these considerations, the characterization of the role of mitochondrial RONS formation in cardiac disease as well as inflammatory processes but also the role of mitochondria as potential therapeutic targets in these pathophysiological states should be addressed in more detail in the future.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22657349      PMCID: PMC3887453          DOI: 10.1089/ars.2012.4609

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  136 in total

1.  Therapeutic targeting of mitochondrial superoxide in hypertension.

Authors:  Anna E Dikalova; Alfiya T Bikineyeva; Klaudia Budzyn; Rafal R Nazarewicz; Louise McCann; William Lewis; David G Harrison; Sergey I Dikalov
Journal:  Circ Res       Date:  2010-05-06       Impact factor: 17.367

2.  Regulation of proliferation of skeletal muscle precursor cells by NADPH oxidase.

Authors:  Mahroo Mofarrahi; Ralf P Brandes; Agnes Gorlach; Joerg Hanze; Lance S Terada; Mark T Quinn; Dominique Mayaki; Basil Petrof; Sabah N A Hussain
Journal:  Antioxid Redox Signal       Date:  2008-03       Impact factor: 8.401

Review 3.  Extending life span by increasing oxidative stress.

Authors:  Michael Ristow; Sebastian Schmeisser
Journal:  Free Radic Biol Med       Date:  2011-05-14       Impact factor: 7.376

4.  Regulation by mitochondrial superoxide and NADPH oxidase of cellular formation of nitrated cyclic GMP: potential implications for ROS signalling.

Authors:  Khandaker Ahtesham Ahmed; Tomohiro Sawa; Hideshi Ihara; Shingo Kasamatsu; Jun Yoshitake; Md Mizanur Rahaman; Tatsuya Okamoto; Shigemoto Fujii; Takaaki Akaike
Journal:  Biochem J       Date:  2012-01-15       Impact factor: 3.857

5.  Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II.

Authors:  Shoji Kimura; Guo-Xing Zhang; Akira Nishiyama; Takatomi Shokoji; Li Yao; Yu-Yan Fan; Matlubur Rahman; Takeo Suzuki; Hajime Maeta; Youichi Abe
Journal:  Hypertension       Date:  2005-04-11       Impact factor: 10.190

Review 6.  Regulation of endothelial cell tetrahydrobiopterin pathophysiological and therapeutic implications.

Authors:  David G Harrison; Wei Chen; Sergey Dikalov; Li Li
Journal:  Adv Pharmacol       Date:  2010

7.  Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.

Authors:  Carola Doerries; Karsten Grote; Denise Hilfiker-Kleiner; Maren Luchtefeld; Arnd Schaefer; Steven M Holland; Sajoscha Sorrentino; Costantina Manes; Bernhard Schieffer; Helmut Drexler; Ulf Landmesser
Journal:  Circ Res       Date:  2007-03-01       Impact factor: 17.367

Review 8.  NADPH oxidases: functions and pathologies in the vasculature.

Authors:  Bernard Lassègue; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-12       Impact factor: 8.311

Review 9.  Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury.

Authors:  Elizabeth Murphy; Charles Steenbergen
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

10.  Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes.

Authors:  D B Zorov; C R Filburn; L O Klotz; J L Zweier; S J Sollott
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  82 in total

Review 1.  Reactive oxygen species in inflammation and tissue injury.

Authors:  Manish Mittal; Mohammad Rizwan Siddiqui; Khiem Tran; Sekhar P Reddy; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2013-10-22       Impact factor: 8.401

2.  Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-studies in white blood cells and in animal models.

Authors:  Swenja Kröller-Schön; Sebastian Steven; Sabine Kossmann; Alexander Scholz; Steffen Daub; Matthias Oelze; Ning Xia; Michael Hausding; Yuliya Mikhed; Elena Zinssius; Michael Mader; Paul Stamm; Nicolai Treiber; Karin Scharffetter-Kochanek; Huige Li; Eberhard Schulz; Philip Wenzel; Thomas Münzel; Andreas Daiber
Journal:  Antioxid Redox Signal       Date:  2013-08-17       Impact factor: 8.401

Review 3.  Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies.

Authors:  Aaron M Swomley; Sarah Förster; Jierel T Keeney; Judy Triplett; Zhaoshu Zhang; Rukhsana Sultana; D Allan Butterfield
Journal:  Biochim Biophys Acta       Date:  2013-10-09

4.  Hypoxia/oxidative stress alters the pharmacokinetics of CPU86017-RS through mitochondrial dysfunction and NADPH oxidase activation.

Authors:  Jie Gao; Xuan-sheng Ding; Yu-mao Zhang; De-zai Dai; Mei Liu; Can Zhang; Yin Dai
Journal:  Acta Pharmacol Sin       Date:  2013-10-14       Impact factor: 6.150

Review 5.  Targeting Oxidative Stress in Central Nervous System Disorders.

Authors:  Manisha Patel
Journal:  Trends Pharmacol Sci       Date:  2016-08-01       Impact factor: 14.819

6.  Stimulatory TSH-Receptor Antibodies and Oxidative Stress in Graves Disease.

Authors:  Tanja Diana; Andreas Daiber; Matthias Oelze; Susanne Neumann; Paul D Olivo; Michael Kanitz; Paul Stamm; George J Kahaly
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

Review 7.  Antioxidant effects of resveratrol in the cardiovascular system.

Authors:  Ning Xia; Andreas Daiber; Ulrich Förstermann; Huige Li
Journal:  Br J Pharmacol       Date:  2016-05-06       Impact factor: 8.739

Review 8.  Reactive species-induced microvascular dysfunction in ischemia/reperfusion.

Authors:  Hong Yu; Ted Kalogeris; Ronald J Korthuis
Journal:  Free Radic Biol Med       Date:  2019-03-05       Impact factor: 7.376

9.  Combined incubation of colon carcinoma cells with phorbol ester and mitochondrial uncoupling agents results in synergic elevated reactive oxygen species levels and increased γ-glutamyltransferase expression.

Authors:  Seila Pandur; Chandra Ravuri; Ugo Moens; Nils-Erik Huseby
Journal:  Mol Cell Biochem       Date:  2013-11-27       Impact factor: 3.396

Review 10.  Circadian redox rhythms in the regulation of neuronal excitability.

Authors:  Mia Y Bothwell; Martha U Gillette
Journal:  Free Radic Biol Med       Date:  2018-02-02       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.